PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-02-07

Date Title Company
07-Feb-2026 Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS) Businesswire